GLP-1 Weight Loss in Europe: Eligibility, Costs & Access
If your BMI is 30+, or 27+ with related health issues like type 2 diabetes or high blood pressure. Access varies by country. In most EU nations, a doctor must diagnose obesity, confirm previous weight loss attempts, and supervise treatment. Private clinics offer more flexibility but require out-of-pocket payments.
Trying to lose weight can feel like a never-ending struggle. Many people across Europe try various diets and exercise plans, but often end up feeling disappointed and frustrated. It doesn't help that there is so much confusing advice, marketing hype, and different healthcare rules from country to country.
Recently, a new type of medicine has given hope to many people. These medicines are called GLP-1 receptor agonists. They were initially created to assist individuals with type 2 diabetes, but doctors have discovered that they can also aid in safe and significant weight loss when used correctly.
But with this exciting new option, many questions come up:
- Am I allowed to use this medicine?
- How can I get it in my country?
- How much does it cost, and what are the risks?
Finding clear answers is not always easy. Every European country has its own unique healthcare system, regulations, and procedures. This often leads to confusion and frustration for individuals seeking trustworthy information.
This guide is here to help. It will give you clear and straightforward information about who can use GLP-1 medicines for weight loss and how to access them across Europe.
In this guide, you will learn:
- What are the eligibility rules in simple terms
- How each country’s process works and what challenges you might face
- What are the most common safety concerns and side effects?
- How to talk to your doctor about this option
You will also see why these medicines work best when used together with healthy lifestyle changes. They are not a quick fix, but they can be a powerful part of a long-term plan for better health.
By the end of this guide, you will have the knowledge you need to take the next steps on your weight loss journey, with help from qualified healthcare professionals.
GLP-1s for Weight Loss: How They Work & Who They Help
What Are GLP-1 Receptor Agonists? (Basics & Mechanism)
GLP-1 receptor agonists are a type of medication that mimics a natural hormone in the body called glucagon-like peptide-1, or GLP-1. This hormone helps control blood sugar and appetite.
When you take a GLP-1 medicine, it works in a few critical ways:
- Helps you feel full faster and reduces hunger
- Slows down how quickly food leaves your stomach, which enables you to feel full for longer
- Helps your body release more insulin when needed, which controls blood sugar
How GLP-1s Support Weight Loss (Appetite & Satiety)
By affecting appetite and digestion, GLP-1 medicines can help you eat less without constantly feeling hungry or deprived.
Here are the main ways they support weight loss:
- You feel less hungry and have fewer food cravings
- You feel full after eating smaller amounts of food
- Your blood sugar is better controlled, which can improve overall health
For many people, this makes it easier to follow a healthier eating plan and lose weight in a steady, long-term way.
GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro)GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro)
Several GLP-1 medicines are now approved in Europe to help with weight management. These include:
- Liraglutide (Saxenda)
- Semaglutide (Wegovy)
- Tirzepatide (Mounjaro) — approved in some European countries and waiting for approval in others.
Always check your country’s national health website or the European Medicines Agency (EMA) for the latest information.
Doctors usually prescribe these medicines as part of a complete weight management plan. This should also include healthy eating, regular physical activity, and support for making lasting changes in habits.
Why GLP-1s? Effectiveness, Metabolic Benefits & Limits
A New Way of Thinking About Obesity
For many years, people were told that losing weight was only about eating less and exercising more. However, science now reveals that obesity is a more complex phenomenon. It is a long-term health condition that various factors, including genetics, hormones, environment, and mental health can influence. It is not just about willpower.
Because of this, many health experts in Europe now see obesity as a long-term disease that often needs medical treatment. It is treated much like other health conditions, such as diabetes or high blood pressure.
Why Are GLP-1 Medicines So Effective?
Research shows that GLP-1 medicines can help people lose significant weight and maintain it. They are among the most effective weight-loss medications available today.
Here is what the research tells us:
- People taking GLP-1 medicines, such as semaglutide or liraglutide, lost approximately 10% to 15% of their body weight in medical studies (source: New England Journal of Medicine).
- Many people also saw improvements in other health problems, such as type 2 diabetes, high blood pressure, and high cholesterol.
Why Is This Important?
Even losing 5% to 10% of your body weight can make a big difference to your health. It can help:
- Lower the risk of heart disease
- Improve blood sugar levels
- Reduce joint pain
- Help you sleep better
- Improve your overall quality of life.
But keeping the weight off can be hard. GLP-1 medicines can make it easier by helping to control hunger and cravings. This allows healthy lifestyle changes to be more effective and sustainable.
Europe-Wide GLP-1 Eligibility: BMI, Comorbidities & Attempts
EMA Approval vs. Country Rules: Coverage & Prescribing
Before a medicine can be used across the European Union, it must first be approved by the European Medicines Agency (EMA). The EMA ensures that medicines are safe, of high quality, and effective. If the EMA approves a drug, it can be used throughout the EU. But here's where it can get tricky.
Each country in Europe then decides how it will allow people to use the medicine. Each country chooses:
- Who can get the medicine
- Whether the medicine is paid for by public healthcare
- How doctors are allowed to prescribe it
As a result, the rules governing who can obtain GLP-1 medicines for weight loss vary by country.
BMI Criteria for GLP-1s (≥30; ≥27 + Comorbidities)
Across Europe, the first step in deciding if someone can use a GLP-1 medicine is often their BMI (Body Mass Index). BMI is a number based on your height and weight. It’s not a perfect measure, but doctors use it to help decide who qualifies.
- If your BMI is 30 or higher, you may qualify because this is considered obesity.
- If your BMI is 27 to 29.9, you may qualify if you also have at least one weight-related health problem.
You can use a simple BMI calculator to find your number.
Here’s how BMI is usually grouped:
- Normal weight
- Overweight
- Obesity
- Severe obesity
Higher BMI is linked to risks such as diabetes, heart disease, and sleep problems.
Comorbidities That Strengthen Eligibility (T2D, HTN, OSA)
If your BMI is between 27 and 30, you will usually need to have at least one related health condition. These may include:
- Type 2 diabetes
- High cholesterol
- High blood pressure (controlled)
- Sleep apnoea (trouble breathing during sleep)
- Heart disease
A qualified medical professional must diagnose these health problems. Self-checking online is not enough.
Documented Weight-Loss Attempts: What Doctors Look For
In many European countries, people must also show that they have already tried to lose weight by:
- Changing their diet
- Doing exercise programmes
- Trying other healthy lifestyle changes
If these efforts did not lead to lasting weight loss, a GLP-1 medicine may then be considered.
It's helpful to be prepared to discuss your weight loss history with your doctor. If you can, bring:
- Notes about diets you have tried
- Details of any exercise or fitness programmes
- A record of your weight over time
This information helps your doctor understand your journey and may support your eligibility for a GLP-1 prescription.
Country Access Guide: UK, Germany, France, Nordics, South
Why Access Varies Across Europe
If a medicine is approved by the European Medicines Agency (EMA), it should be easily accessible in all European Union countries. But this is not true.
Each country has its own healthcare system and its own set of rules. This means that each country decides:
- Who can get the medicine
- How doctors are allowed to prescribe it
- If public healthcare will help pay for it
- How easy it is to get the medicine (supply)
Due to this, obtaining GLP-1 medicines for weight loss in Europe can be a confusing process. What works in one country might not work in another.
This section provides a concise overview of how things work in some key European countries.
GLP-1 Access by Country (At-a-Glance 2025 Snapshot)
| Country | BMI Requirement | Comorbidity Needed (27–29.9) | Public Coverage | Typical Private Cost | Prescribing Path |
|---|---|---|---|---|---|
| UK | ≥30 (≥35 often NHS), or ≥30 + comorbidity | Yes | Limited via NHS tiers | £150–£300/mo | NHS referral or CQC-licensed private clinic |
| Germany | ≥30, or ≥27 + comorbidity | Yes | Rare for weight loss | €250–€350/mo | Endocrinologist/obesity specialist/private GP |
| France | ≥30, or ≥27 + comorbidity | Yes | Limited (case-by-case, Saxenda) | €200–€350/mo | GP + specialist centres/private clinics |
| Denmark | ≥30, or ≥27 + comorbidity | Yes | Partial in severe cases | DKK 2,000–3,500 | Public referral or private clinic |
| Sweden | ≥30, or ≥27 + comorbidity | Yes | Very limited | SEK 2,500–4,000 | Private clinics common |
| Norway | ≥30, or ≥27 + comorbidity | Yes | Regional variation | NOK 2,500–4,000 | Private clinics; regional rules |
| Spain | ≥30, or ≥27 + comorbidity | Yes | Rare | €250–€350/mo | Private obesity clinics |
| Italy | ≥30, or ≥27 + comorbidity | Yes | Limited, severe cases | €250–€350/mo | Specialists/bariatric centres/private GP |
Why There Is No One-Size-Fits-All Answer
As you can see, there is no simple way to access GLP-1 medicines across Europe.
- In some countries, such as the UK, public healthcare (NHS) provides these medicines through specialised weight management services; however, there are strict rules and long waiting lists.
- In countries like Germany and Spain, many people get the medicine through private doctors and pay for it themselves.
- Whether public healthcare covers the cost varies significantly from country to country.
Key Thing to Remember
Before starting treatment, it is essential to understand the regulations in your own country. Be prepared to discuss this with your doctor so you know what to expect.
UK: NHS vs Private Access, Criteria & Costs
NHS Access: Structured but Limited
In the UK, getting GLP-1 medicines for weight loss through the National Health Service (NHS) is not simple. These medicines are not typically prescribed by regular GPs solely for weight loss.
To access the NHS, most people need to be referred to a specialist weight management service. These are sometimes called Tier 3 or Tier 4 services, depending on where you live.
NHS Criteria for GLP-1 Prescriptions
The NHS has strict rules for who can get GLP-1 medicines. You usually need to meet these conditions:
- A BMI of 35 or higher, or 30 or higher if you have other health problems like diabetes or heart disease
- You must have already tried to lose weight through diet, exercise, or other healthy changes
- You must go through a full health check with an NHS weight management service
- You must take part in a lifestyle change programme while using the medicine
Important: There is often a waiting list for these NHS services. How long you wait depends on where you live. Many people report delays because these services are hectic.
You can read the full NHS guidelines on obesity management.
Private Options in the UK
If you do not meet the NHS criteria or prefer not to wait, you can obtain a private prescription. These are available from:
- Private doctors who specialise in obesity
- Private GPs or clinics
- Regulated online clinics that are registered with the Care Quality Commission (CQC)
Private treatment offers more flexibility, but you must pay for it yourself. Prices usually range from:
- £150 to £300 per month for semaglutide (Wegovy)
- £100 to £200 per month for liraglutide (Saxenda)
Tip: Always buy GLP-1 medicines from registered healthcare providers or licensed pharmacies. Avoid websites that are not regulated, as they may sell unsafe or fake products.
Specific Drug Availability
- Wegovy is now approved and available for weight management in the UK. It is used in some NHS services and is also available privately.
- Saxenda is still widely available through private doctors and some NHS services.
- Ozempic is not approved for weight loss. It is approved for the treatment of type 2 diabetes, although some doctors may also use it for weight loss in some instances.
Supply Shortages
In late 2024 and early 2025, the UK had significant shortages of GLP-1 medicines, especially:
- Wegovy, because demand is very high
- Ozempic, which caused problems for some diabetes patients
If you are considering starting treatment, discuss the available options with your doctor. They can also help you plan what to do if supplies are delayed.
Germany: Eligibility, Specialists & Out-of-Pocket Costs
Reimbursement Status: Mostly Out-of-Pocket
In Germany, GLP-1 medicines, such as Wegovy and Saxenda, are approved to aid in weight loss. However, they are usually not covered by public health insurance, known as Gesetzliche Krankenversicherung (GKV).
If the medicine is prescribed for type 2 diabetes, some GLP-1 medicines, such as Ozempic, are covered by the GKV.
However, if the medicine is prescribed solely for weight loss, most patients are required to pay the full cost themselves.
As a result, many people in Germany pay for GLP-1 treatment out of pocket.
Typical Costs
If you get a private prescription, here are the usual costs:
- About €250 to €350 per month for semaglutide (Wegovy)
- About €200 to €300 per month for liraglutide (Saxenda)
Prices can vary between different pharmacies and depend on the amount of supply available.
The Role of Specialists
In Germany, GLP-1 medicines for weight loss are often prescribed by:
- Endocrinologists (hormone doctors)
- Obesity specialists (Adipositas-Spezialisten)
- Private weight management clinics
Some family doctors (GPs) may also offer private prescriptions; however, it is advisable to consult a specialist. Specialists can provide a comprehensive treatment plan and offer support with lifestyle changes as well.
Why Seeing a Specialist Helps
In Germany, going to a specialist centre may improve your results. Many specialist clinics offer complete programmes. These include:
- The right medicine
- Nutrition advice
- Help with healthy eating
- Support for changing habits
Combining these things can give better long-term results than using medicine alone.
Supply Availability
Currently, the private supply of Wegovy and Saxenda is generally more robust in Germany than in some other countries. But shortages can still happen, especially with semaglutide.
It is essential to check with your doctor and pharmacy about current availability in your area.
France: Eligibility, Coverage Nuances & Availability
Reimbursement and Access: A Mixed Picture (France)
In France, GLP-1 medicines, such as Wegovy and Saxenda, are approved to aid in weight loss.
But who can get them, and whether the government helps pay for them — depends on your situation.
Saxenda may be partly paid for if you have severe obesity and other health problems.
Wegovy is usually only available through private doctors. It is not currently covered by public health insurance (as of early 2025).
Public healthcare decisions in France are guided by the Haute Autorité de Santé (HAS) and the national health insurance system, Assurance Maladie.
You can check the HAS website for the latest rules on coverage.
Typical Eligibility Criteria
To get a GLP-1 prescription in France, either through public or private healthcare, you usually need:
- A BMI of 30 or higher (obesity), or
- A BMI of 27 or higher if you also have health problems such as:
- Type 2 diabetes
- High blood pressure
- Heart disease
Doctors also often ask for proof that you have already tried to lose weight by changing your lifestyle.
The Role of Specialists
In France, GLP-1 medicines for weight loss are usually prescribed by:
- Endocrinologists (hormone doctors)
- Obesity specialists (médecins spécialisés en obésité)
- Special hospital-based centres for treating obesity and metabolic problems
Your family doctor (GP) can also prescribe these medicines, but they often do this after speaking with a specialist. Many patients follow an organised care plan that includes both the GP and specialist.
Why Seeing a Specialist Can Help
If you are thinking about GLP-1 treatment in France, it is a good idea to ask your GP for a referral to an obesity specialist or centre. This may help if you are hoping to qualify for some public support for Saxenda.
Private Costs
If you get a private prescription, here are the typical monthly costs:
- About €250 to €350 per month for Wegovy
- About €200 to €300 per month for Saxenda
If you do not qualify for public support, you will need to pay these costs yourself.
Drug Availability
As of 2025:
- Wegovy is available through private doctors, but supplies can sometimes run low.
- Saxenda is more widely available, but public support is limited to strict cases based on eligibility rules.
- Ozempic is approved only for the treatment of diabetes. Some doctors may prescribe it off-label for weight loss, but it is not typically covered in this case.
Nordics: Access, Partial Coverage & Lifestyle Programs
The Nordic countries, Denmark, Sweden, and Norway, all have excellent public healthcare. However, access to GLP-1 medicines for weight loss varies from country to country.
In general:
- GLP-1 medicines are approved and available in all three countries
- Many people get these medicines through private doctors
- Public healthcare usually has strict rules about who can get the medicine paid for
Denmark: Progressive Access with Lifestyle Focus
Denmark is one of the Nordic countries most open to using GLP-1 medicines for weight loss.
Both Wegovy and Saxenda are approved for the treatment of obesity.
Public healthcare may pay for these medicines if you have severe obesity and serious health problems. However, many people opt to obtain them through private doctors and pay for them themselves.
Denmark strongly encourages combining GLP-1 treatment with lifestyle changes. Patients are often asked to participate in supervised programs that include diet, exercise, and behavioral support.
In Denmark, joining a complete lifestyle programme can help you get better results and may also improve your chances of qualifying for public support.
Sweden: Private-Driven Market with Growing Demand
In Sweden:
- Wegovy and Saxenda are both approved for obesity treatment
- Public healthcare usually pays for these medicines only for people with type 2 diabetes or severe health problems
- The private market is growing fast. Many people now get these medicines through private clinics.
Typical private costs in Sweden are approximately SEK 2,500 to 4,000 per month (approximately €220 to €350), depending on where you obtain the medicine.
Norway: Similar to Sweden, with Regional Variations
In Norway:
- Wegovy and Saxenda are both approved
- Public healthcare only covers the cost of these medicines for diabetes treatment. For weight loss, you must usually pay yourself unless you have severe health problems.
- Access to GLP-1s for weight loss is mostly through private doctors
Each region in Norway can have slightly different rules. It is a good idea to check with your local obesity centre or specialist doctor for advice.
Shared Nordic Trends
Across Denmark, Sweden, and Norway:
- Endocrinologists (hormone doctors), obesity specialists, and private weight clinics play a significant role in prescribing GLP-1 medicines
- Doctors encourage using these medicines together with healthy lifestyle changes, not as the only solution
- There have been supply shortages, especially for Wegovy, as more people seek these treatments.
Spain & Italy: Private Access, Emerging Public Pathway
An Emerging Landscape for GLP-1 Access
In Southern Europe, access to GLP-1 medicines for weight loss is still developing. In both Spain and Italy, public healthcare usually does not cover these medicines for weight loss alone.
- Wegovy and Saxenda are both approved for weight management in Spain and Italy
- Public healthcare usually does not cover them — most people obtain them through private doctors and pay for them themselves.
Interest in using these medicines is growing, but access still depends on the region and whether you use public or private healthcare.
Spain: Private Market Leading the Way
In Spain:
- Wegovy and Saxenda are approved for weight management
- Most people get these medicines through private doctors and pay out of their own pocket
- Public healthcare usually only covers these medicines for treating type 2 diabetes
- Some regions are testing small public access programmes, but they are not common yet
Private costs in Spain:
- About €250 to €350 per month for Wegovy
- About €200 to €300 per month for Saxenda
Who prescribes GLP-1s in Spain?
- Endocrinologists (hormone doctors)
- Obesity specialists
- Private weight loss clinics
- Some private GPs
In Spain, many patients go to private obesity clinics. These often offer comprehensive programs that include medical advice, nutrition guidance, and support for healthy behavior changes.
Italy: Growing Private Sector, Limited Public Funding
In Italy:
- Wegovy and Saxenda are both approved for obesity treatment
- Most people get these medicines through private doctors
- Public healthcare may cover these medicines in exceptional cases, but only for people with very severe obesity and serious health problems
- National rules are slowly changing, but public coverage is still limited and not consistent across the country
Private costs in Italy:
- About €250 to €350 per month for Wegovy
- About €200 to €300 per month for Saxenda
Who prescribes GLP-1s in Italy?
- Endocrinologists
- Obesity specialists
- Bariatric surgeons (for patients before or after weight loss surgery)
- Private GPs and clinics
In Italy, going to an accredited centro di obesità (obesity centre) can give you access to a full treatment plan. It may also help increase your chances of securing public support, where available.
Shared Southern European Trends
In both Spain and Italy:
- Public healthcare is still very cautious about paying for GLP-1 medicines for weight loss
- The private market is growing fast — more patients are choosing to pay privately
- More private clinics are now offering full weight management programmes that combine GLP-1 treatment with nutrition advice and psychological support
- Supply shortages for Wegovy have been reported in both countries.
Why You Need Specialist Oversight for GLP-1 Therapy
Why Professional Guidance Matters
GLP-1 medicines are powerful, but they may not be suitable for everyone. You should only use them under the care of a qualified healthcare professional. This helps ensure:
- Safe use of the medicine
- Correct dose for your needs
- Support with making healthy lifestyle changes
- Regular check-ups to monitor your progress
Trying to get GLP-1 medicines without a doctor’s help — for example, from unregulated online sellers — is risky and should be avoided.
Who Prescribes GLP-1s?
In most European countries, the following healthcare professionals can prescribe GLP-1 medicines:
- General Practitioners (GPs) — usually your first contact. They may prescribe the medicine or refer you to a specialist.
- Endocrinologists — doctors who treat hormone-related problems, including obesity and type 2 diabetes.
- Obesity specialists — doctors trained to treat obesity.
- Bariatric surgeons sometimes use GLP-1s before or after weight loss surgery.
- Specialised weight management clinics — these offer a team approach, combining medicine with nutrition, exercise, and mental health support.
If your GP does not have much experience with GLP-1 treatment, you can ask for a referral to a specialist or a weight management clinic.
The Comprehensive Medical Evaluation
Before starting GLP-1 treatment, your doctor will usually do a full health check. This may include:
- Looking at your medical history
- Doing a physical exam
- Running blood tests (to check blood sugar, cholesterol, liver, and kidney health)
- Checking for other weight-related health problems
- Talking about your past weight loss efforts
This helps the doctor decide if GLP-1 treatment is right and safe for you.
The Importance of Openness
To get the best results, it is essential to be honest with your doctor about:
- Your complete health history
- Any medicines or supplements you are taking
- What weight loss methods have you tried before
- Your lifestyle: eating habits, activity level, stress, sleep, and mental health
This helps your healthcare team create a plan that fits your needs and lowers risks.
Beyond BMI: A Holistic Approach
Good doctors look at more than just your BMI. They also consider:
- Your mental health and how you relate to food
- Any other health problems you may have
- How motivated and ready are you to make lifestyle changes
- The kind of support you have from family and friends
Before starting GLP-1 treatment, talk with your doctor about:
- Possible side effects
- Any reasons why you should not take the medicine
- How the medicine may interact with other drugs you are taking
This helps ensure your treatment is safe and tailored to your specific needs.
GLP-1 Safety: Side Effects, Contraindications & Monitoring
Why Safety Matters
GLP-1 medicines can aid in weight loss, but like all medications, they can cause side effects and are not suitable for everyone.
Knowing about possible risks can help you:
- Understand what to expect
- Manage common side effects
- Recognise the warning signs of serious problems
- Make a good decision with your doctor
Common Side Effects
Most people do well on GLP-1 medicines, but the most common side effects affect the stomach and digestion, especially in the first few weeks.
Common side effects include:
- Feeling sick (nausea)
- Vomiting
- Diarrhoea
- Constipation
- Indigestion or bloating
These problems usually improve over time as your body becomes accustomed to the medicine.
How to manage them:
- Start with a low dose and slowly increase it (your doctor will plan this for you)
- Eat small meals more often and avoid big portions
- Eat slowly and chew your food well
- Drink plenty of water
Other Mild Side Effects
Some people also notice:
- Headaches
- Feeling tired
- Mild dizziness
These side effects usually do not last long.
Serious but Rare Side Effects
Some rare side effects can be severe. If you notice any of these, get medical help right away.
Pancreatitis (inflammation of the pancreas)
Watch for:
- Bad stomach pain that does not go away (may spread to your back)
- Feeling sick and vomiting that does not stop
Gallbladder problems
GLP-1 medicines can slightly increase the risk of gallstones or gallbladder inflammation.
Watch for:
- Sudden pain in the upper stomach, especially after eating fatty food
- Fever, feeling sick, vomiting
Thyroid tumours (seen in animal studies)
In animal tests, some GLP-1 medicines were linked to a type of thyroid cancer called medullary thyroid carcinoma (MTC). This has not been clearly shown in humans, but doctors are careful about it.
You should not take GLP-1 medicines if you have:
- A personal or family history of MTC
- A rare genetic condition called Multiple Endocrine Neoplasia type 2 (MEN2)
Low blood sugar (hypoglycaemia)
GLP-1 medicines alone usually do not cause low blood sugar. But if you take them with insulin or some diabetes medicines, your risk goes up.
Watch for:
- Feeling shaky
- Sweating
- Fast heartbeat
- Dizziness or confusion
Who Should Not Take GLP-1 Medicines (Contraindications)
You should not take GLP-1 medicines if you have:
- A personal or family history of MTC
- MEN2
- Severe kidney disease
- Severe stomach or gut problems (such as gastroparesis)
- Are pyou regnant or breastfeeding
When to Be Careful
Talk carefully with your doctor if you have:
- A history of pancreatitis
- Severe heart failure
- Specific other serious health problems
Drug Interactions and Precautions
Always tell your doctor about all the medicines and products you are taking, including:
- Prescription medicines
- Over-the-counter medicines
- Herbal products or supplements
This helps avoid dangerous interactions.
Before starting GLP-1 treatment, ask your doctor to review all your medicines to make sure the treatment will be safe for you.
Cost & Reimbursement in Europe: Prices, Shortages, Strategy
The High Cost of GLP-1 Medications
One of the biggest challenges for many people thinking about GLP-1 treatment is the cost.
These medicines can be expensive, especially if you have to pay for them yourself. Typical costs in Europe:
- €200 to €350 per month for Wegovy
- €200 to €300 per month for Saxenda
- €250 to €400 per month for Mounjaro (in countries where approved for weight loss)
Prices vary between countries, pharmacies, and based on supply.
Long-Term Financial Commitment
It is essential to know that GLP-1 treatment usually lasts a long time:
- Weight loss happens slowly, often over several months
- Many people need to keep taking the medicine to keep the weight off
- If you stop the treatment, weight often comes back, so planning is important
When you talk with your doctor, ask how long you might need to take the medicine — and if the cost will be manageable for you.
Navigating Insurance Coverage and Reimbursement
Public health coverage is very different across Europe:
- In some countries (such as Denmark and, in some cases, France), public healthcare may cover part of the cost for certain patients
- In many countries (such as Germany, Spain, and Italy), most people have to pay the full cost unless they are being treated for type 2 diabetes
- Even when public coverage is feasible, obtaining approval can be a lengthy and complex process.
Public vs Private Healthcare
|
System |
Typical situation for weight loss treatment |
|
Public healthcare (NHS, GKV, etc.) |
Often no coverage or very limited |
|
Private insurance |
Varies — some policies cover part of the cost if there is a medical need |
|
Paying yourself (out-of-pocket) |
Very common in many European countries |
Before starting treatment, carefully review your insurance and national guidelines. Whether it is covered often depends on:
- Your BMI
- If you have other health problems
- Whether a specialist referred you
GLP-1 Drug Pricing (Typical Costs as of 2025)
|
Medicine |
Typical monthly cost (private) |
|
Wegovy |
€200 to €350 |
|
Saxenda |
€200 to €300 |
|
Mounjaro |
€250 to €400 |
|
Ozempic |
Covered mainly for diabetes, not for weight loss |
Note: Ozempic is not approved for weight loss, though some doctors use it off-label. It is not safe to use it in this manner without clear guidance from your doctor.
Supply Chain Issues and Shortages
Across Europe, there have been shortages of GLP-1 medicines, which affect both diabetes and weight loss patients.
Reasons for shortages:
- Very high demand for weight loss treatment
- Limited production
- Priority given to diabetes patients first
Countries reporting shortages in 2025:
- United Kingdom
- Germany
- France
- Spain
- Italy
- Denmark
- Sweden
To help manage this:
- Plan your prescription refills ahead of time
- Be flexible about the brand or dose if needed
- Be aware that temporary supply issues may occur.
Strategies for Accessing Medication
Private purchase: The most common way to get GLP-1 medicines for weight loss in many European countries is through a private doctor.
Patient assistance programmes: These are rare for weight loss, but sometimes available from drug companies or local health services. It is worth checking with your doctor or through the official websites of companies like Novo Nordisk orEli Lilly.
Warning about unregulated online sources: Never buy GLP-1 medicines from unregulated websites or unofficial sellers. The risks include:
- Fake products
- Wrong doses
- Dangerous ingredients
- Serious health risks
Always get GLP-1 medicines from a licensed doctor and an approved pharmacy.
This section is based on national healthcare websites, updates from the European Medicines Agency (EMA), and official news from the companies that make these medicines. You should always confirm the latest rules and prices in your country with your doctor or pharmacist, as they can change.
Conclusion: Safe Access, Lasting Habits & Next Steps
Navigating the world of GLP-1 medicines for weight loss in Europe can feel confusing. Different rules in each country, supply issues, and safety concerns can make it challenging to determine the best course of action.
But here is the good news: you don’t have to do this alone.
Now that you understand:
- Who can get GLP-1 treatment
- How to access it safely and legally in your country
- Why working with a trusted healthcare professional is important
- Why lifestyle changes should go hand in hand with the medicine
You are ready to take the next step toward a healthier future.
GLP-1 medicines are not a magic cure. However, when used as part of a comprehensive, doctor-supervised plan, they can help many people lose weight safely and maintain their weight loss.
How Mobi Doctor Can Help
If you think GLP-1 treatment might be proper for you, or if you want to learn more, Mobi Doctor can help.
Through Mobi Doctor, you can:
- Talk to a qualified GP or specialist online
- Get advice that fits your country and healthcare system
- Find out if GLP-1 treatment is a good option for you
- Understand your next steps, whether starting treatment or getting a referral to a specialist.
